The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018 (CME Videos)

Brigham and Women’s Hospital Board Review

This comprehensive CME program offers an in-depth, case-base review of the clinical essentials in hematology and oncology. Ideal for MOC.

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. Relevant topics are addressed in case-based board review presentations. Improve patient care by learning to:

• Perform differential diagnosis of complex hematologic and oncologic disorders
• Identify and apply current therapeutic options for hematologic and oncologic disorders
• Evaluate and interpret up-to-date literature relevant to hematology and oncology
• Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
• Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
• Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

• Molecular Genetics of Cancer – Nikhil Wagle, MD

• Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

• Infections in Cancer Patients – Lindsey Baden, MD

• Symptom Management in Patients with Cancer – Janet L. Abrahm, MD

• Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD

• Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

• Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

• Acute Leukemias – Daniel J. DeAngelo, MD, PhD

• Myelodysplastic Syndrome – David P. Steensma, MD

• Chronic Myelogenous Leukemia – Joseph H. Antin, MD

• Myeloproliferative Syndromes – Ann M. Mullally, MD

• Multiple Myeloma – Kenneth C. Anderson, MD

• Waldenstrom Macroglobulinemia, Amyloidosis – Irene M. Ghobrial, MD

• Low Grade Lymphomas – Caron A. Jacobson, MD

• High Grade Lymphomas – Eric D. Jacobsen, MD

• Hodgkin’s Lymphoma – Ann S. LaCasce, MD

• Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

• Head and Neck Cancer – Robert I. Haddad, MD

• Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD

• Non Small Cell Lung Cancer – Mark Awad, MD, PhD
  

• Mesothelioma and Thymoma – David M. Jackman, MD

• Thyroid Cancer – Jochen Lorch, MD

• Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD

• Esophageal and Gastric Cancer – Peter C. Enzinger, MD

• Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD

• Anal Cancers – Robert J. Mayer, MD

• Colorectal Cancers – Robert J. Mayer, MD

• Gastrointestinal Cancer – Genetic Syndromes – Matthew Yurgelun, MD

• Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD

• Renal and Bladder Cancer – Toni K. Choueiri, MD

• Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD

• Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD

• Melanoma – F. Stephen Hodi, MD

• Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

• Ovarian Cancer – Ursula A. Matulonis, MD

• Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

• Neuro-oncology – David A. Reardon, MD

• Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH

• Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD

• Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD

• Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

• Hematopoiesis and Cytokines – David T. Scadden, MD

• Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

• Congenital Bone Marrow Failure – David A. Williams, MD

• Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

• Anemia: An Overview – Ronald P. McCaffrey, MD

• Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

• Immune Hemolytic Anemia – Richard M. Kaufman, MD

• Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

• Sickle Cell Disease – Maureen M. Achebe, MD, MPH

• Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

• Disorders of Neutrophils – Nancy Berliner, MD

• Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

• Hemophilia – Aric D. Parnes, MD

• Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

• Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

• New Oral Anticoagulants – Jean M. Connors, MD

• Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Learning Objectives

Upon completion of this activity, the participant will be able to:

• Apply current/recommended Hematology and Oncology guidelines in clinical practice
• Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
• Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
• Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
• Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
• Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing Hematology and Oncology specialists (MDs), and other professional affiliates (internists with an interest in Hematology and Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology and Oncology Medicine.

Date of Original Release: June 30, 2018
Termination Date: June 30, 2021